PATH Rule 144 Notice: 16,083 Common Shares Through Morgan Stanley

Rhea-AI Filing Summary

UiPath, Inc. (PATH) reported a proposed Rule 144 sale of 16,083 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $202,002.48. The shares are scheduled for sale approximately on 09/30/2025 on the NYSE. The filer acquired the shares as Restricted Stock Units from the issuer on 07/01/2023, with the acquisition and payment date recorded as 07/01/2023. The filing notes no securities sold by the account in the past three months. Several standard notice fields such as signature and specific filing dates are presented but no entries are shown in the provided content.

Positive

• Acquisition via RSUs indicates the shares derive from standard employee compensation rather than external transactions
• Broker identified (Morgan Stanley Smith Barney LLC), showing an established execution channel for the planned sale
• No sales in past three months reported for the account, reducing near-term dilution concerns

Negative

• Filing excerpt does not show signature or explicit notice date, leaving procedural completion unclear
• Remarks fields are present but unpopulated in the provided content, limiting confirmation of Rule 10b5-1 plan or other instructions

Insights

Securities Analyst

TL;DR: Routine Section 144 notice for a modest sale of 16,083 shares; no recent sales reported and acquisition was via RSUs.

The filing documents a proposed sale under Rule 144 of 16,083 common shares, acquired as restricted stock units on 07/01/2023 and intended for sale on 09/30/2025 through Morgan Stanley Smith Barney LLC. The aggregate market value is recorded as $202,002.48 and the issuers outstanding shares are shown as 453,568,899. This size represents a de minimis fraction of total outstanding shares, indicating the transaction is unlikely to be market moving. The filing contains standard representations but lacks populated signature and date details in the provided extract.

Corporate Governance Expert

TL;DR: Disclosure reflects an employee-derived holding (RSUs) being liquidated under Rule 144; procedural completeness appears partial in this excerpt.

The securities were acquired from the issuer as restricted stock units, which is typical for employee compensation. The use of Rule 144 for an orderly sale is conventional. The filing lists the broker and sale mechanics but the excerpt does not show completed signature or notice dates, which are required for full procedural record. From a governance viewpoint, the filing content provided is routine and informational, not indicative of corporate governance concerns on its face.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	16083	202002.48	453568899	09/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2023	Restricted Stock Units	Issuer			16083	07/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is being sold in the UiPath (PATH) Form 144 filing?

The filing shows a proposed sale of 16,083 common shares of UiPath with an aggregate market value of $202,002.48.

When were the UiPath shares acquired that are listed in the Form 144?

The shares were acquired as Restricted Stock Units on 07/01/2023 and payment is recorded as 07/01/2023.

Who is the broker for the proposed PATH share sale?

The broker listed is Morgan Stanley Smith Barney LLC with an address at Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

When is the approximate date of sale in the Form 144 for PATH?

The approximate date of sale is listed as 09/30/2025 on the NYSE.

Has the person for whose account the securities are to be sold reported any sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.